Table 2. Demographic and clinical data of convalescents after liver transplantation and matched non-immunosuppressed comparators.
| Pre-pandemic | 1–2 months p |
3–4 months p |
≥ 5 months non-vacc p. |
≥ 5 months vacc. p |
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OLT (n = 16) | OLT (n = 15) | non-IS-Con (n = 14) | OLT (n = 16) | non-IS-Con (n = 16) | OLT (n = 3) | non-IS-Con (n = 34) | OLT (n = 14) | non-IS-Con (n = 11) | ||||||
| Sex | male (n;%) | 10; 62.5 | 9; 60 | 8; 57.1 | .881 | 9; 56.3 | 10; 62.5 | .729 | 2; 66.7 | 25; 74 | .858 | 8; 57.1 | 4; 36.4 | .322 |
| Age | median (min; max) | 56 (20;68) | 56 (25;68) | 51 (32; 60) | .649 | 56 (22;72) | 46 (21;68) | .780 | 56 (20;68) | 50 (27;57) | .906 | 56 (32; 72) | 50 (27;57) | .162 |
| Time after diagnosis in weeks | median (min; max) | 6 (3;8) | 6 (4;8) | .707 | 15 (9;20) | 12 (9;17) | .730 | 26 (25; 30) | 59 (36,65) | .154 | 29 (24;56) | 59 (36;65) | .000 | |
| Inpatient | yes (n;%) | 2; 13.3 | 0; 0 | .678 | 3; 18 | 0; 0 | .715 | 2; 66.7 | 0; 0 | .953 | 1; 7.1 | 0; 0 | .088 | |
| WHO clinical progression scale | 1 | 3 | 1 | 3 | 1 | 1 | 0 | 6 | 2 | |||||
| 2 | 11 | 12 | 11 | 14 | 1 | 33 | 7 | 7 | ||||||
| 3 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | ||||||
| 4 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 2 | ||||||
(p-values compare OLT and non-IS-Con at the time point after COVID-19 disease, pre-pandemic samples are not compared to another group).